Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Pension (2016 - 2021)

Oramed Pharmaceuticals filings provide 11 years of Pension readings, the most recent being $20000.0 for Q2 2021.

  • Quarterly Pension rose 17.65% to $20000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $20000.0 through May 2021, up 17.65% year-over-year, with the annual reading at $18000.0 for FY2020, 18.18% down from the prior year.
  • Pension hit $20000.0 in Q2 2021 for Oramed Pharmaceuticals, roughly flat from $20000.0 in the prior quarter.
  • Across five years, Pension topped out at $22000.0 in Q3 2019 and bottomed at $17000.0 in Q1 2017.
  • Average Pension over 5 years is $19000.0, with a median of $19000.0 recorded in 2017.
  • The largest annual shift saw Pension soared 38.46% in 2017 before it dropped 19.05% in 2020.
  • Oramed Pharmaceuticals' Pension stood at $19000.0 in 2017, then increased by 5.26% to $20000.0 in 2018, then dropped by 15.0% to $17000.0 in 2019, then increased by 11.76% to $19000.0 in 2020, then increased by 5.26% to $20000.0 in 2021.
  • Per Business Quant, the three most recent readings for ORMP's Pension are $20000.0 (Q2 2021), $20000.0 (Q1 2021), and $19000.0 (Q4 2020).